The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1487774
WO Application Number:
US2003005521
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP03711221.6
WO Publication Number:
WO2003072734
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
25/02/2003
Grant date:
19/09/2018
EP Publication Date:
22/12/2004
WO Publication Date:
04/09/2003
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
19/09/2018
EP B1 Publication Date:
19/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
24/02/2023
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
19/09/2018
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
19/09/2018
Name:
Diffusion Pharmaceuticals LLC
Address:
999 Grove Street,
Suite 203, Charlottesville, VA 22902, United States of America (US)
Inventor
1
Name:
GAINER, John, L.
Address:
Charlottesville, VA 22903, United States of America (US)
2
Name:
GRABIAK, Raymond, C.
Address:
Maryland Heights, MO 63403, United States of America (US)